Merck signs deal with Jiangsu Hengrui worth up to $2 billion for access to heart drug
Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...
China Daily11d
Jiangsu arts group announces week of performances
On March 20, the Jiangsu Performing Arts Group announced the lineup of its theater festival week in Beijing, with four stage ...
Shanghai Metals Market3d
Lead Prices Reversed and Pulled Back, Spot Market Transactions Showed Significant Divergence [SMM Midday Review]
Lead Prices Reverse and Pull Back, Spot Market Transactions Show Significant Divergence】 SMM March 28: In the Shanghai market, Chihong lead was quoted at 17,425-17,475 yuan/mt, with a premium of 0-50 ...
pharmaphorum6d
MSD licenses Lp(a) heart drug from Hengrui in $2bn deal
MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp (a) inhibitor from China's Jiangsu Hengrui ...